Study links microaneurysm turnover to CSME onset

12/9/2012 | Medscape (free registration)

Type 2 diabetes patients with mild nonproliferative diabetic retinopathy who developed clinically significant macular edema showed higher average microaneurysm turnover than those who did not develop CSME, according to a study in Diabetes Care. Researchers also found an MA turnover value of nine or higher had a 57.7% sensitivity and an 81.2% specificity in forecasting CSME onset within two years.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX